179 related articles for article (PubMed ID: 9503181)
1. Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCA.
van de Loo A; Nauck M; Noory E; Just H; Wollschläger H
Eur Heart J; 1998 Jan; 19(1):96-102. PubMed ID: 9503181
[TBL] [Abstract][Full Text] [Related]
2. Ticlopidine and aspirin fail to suppress the increased platelet aggregability that follows percutaneous coronary interventions.
Fischetti D; Sciahbasi A; Leone AM; Niccoli G; Schiavoni G; Trani C; Mazzari MA; Andreotti F
J Thromb Thrombolysis; 2000 Dec; 10(3):265-9. PubMed ID: 11122547
[TBL] [Abstract][Full Text] [Related]
3. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures.
Gregorini L; Marco J; Fajadet J; Bernies M; Cassagneau B; Brunel P; Bossi IM; Mannucci PM
J Am Coll Cardiol; 1997 Jan; 29(1):13-20. PubMed ID: 8996289
[TBL] [Abstract][Full Text] [Related]
4. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
Lepäntalo A; Virtanen KS; Heikkilä J; Wartiovaara U; Lassila R
Eur Heart J; 2004 Mar; 25(6):476-83. PubMed ID: 15039127
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
[TBL] [Abstract][Full Text] [Related]
6. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study.
Gajos G; Rostoff P; Undas A; Piwowarska W
J Am Coll Cardiol; 2010 Apr; 55(16):1671-8. PubMed ID: 20394870
[TBL] [Abstract][Full Text] [Related]
7. Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions.
Kleiman NS; Grazeiadei N; Maresh K; Taylor RJ; Frederick B; Lance ET; Effron MB; Jordan RE; Mascelli MA
Am Heart J; 2000 Sep; 140(3):492-501. PubMed ID: 10966553
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
[TBL] [Abstract][Full Text] [Related]
9. [The effects of post coronary stenting triple antiplatelet therapies on platelet functions].
Han YL; Su QF; Li Y; Kang J; Yan CH; Wang SL
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):635-8. PubMed ID: 17074146
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial.
Lim E; Cornelissen J; Routledge T; Kirtland S; Charman SC; Bellm S; Munday H; Khan O; Masood I; Large S
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):432-5. PubMed ID: 15354104
[TBL] [Abstract][Full Text] [Related]
11. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
Kojuri J; Mahmoody Y; Zangbar Sabegh B; Jannati M; Mahboodi A; Khalili A
Cardiovasc Ther; 2010 Jun; 28(3):147-52. PubMed ID: 20557313
[TBL] [Abstract][Full Text] [Related]
12. [Reduction of in-hospital complications after elective percutaneous transluminal coronary angioplasty using a combined pretreatment with ticlopidine and aspirin].
Reffelmann T; vom Dahl J; Hendriks F; Klues HG; Hanrath P
Z Kardiol; 1998 Nov; 87(11):872-80. PubMed ID: 9885180
[TBL] [Abstract][Full Text] [Related]
13. [Antiplatelet therapy in cardiac diseases].
Aosaki M; Iwade K; Kimata S; Hosoda S
Nihon Rinsho; 1992 Feb; 50(2):397-402. PubMed ID: 1613997
[TBL] [Abstract][Full Text] [Related]
14. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D
Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744
[TBL] [Abstract][Full Text] [Related]
15. Earlier application of loading doses of aspirin and clopidogrel decreases rate of recurrent cardiovascular ischemic events for patients undergoing percutaneous coronary intervention.
Tang FK; Lin LJ; Hua N; Lu H; Qi Z; Tang XZ
Chin Med J (Engl); 2012 Feb; 125(4):631-8. PubMed ID: 22490487
[TBL] [Abstract][Full Text] [Related]
16. Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy.
Wadowski PP; Eichelberger B; Kopp CW; Pultar J; Seidinger D; Koppensteiner R; Lang IM; Panzer S; Gremmel T
J Cardiovasc Transl Res; 2017 Aug; 10(4):359-367. PubMed ID: 28425039
[TBL] [Abstract][Full Text] [Related]
17. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
Parodi G; Marcucci R; Valenti R; Gori AM; Migliorini A; Giusti B; Buonamici P; Gensini GF; Abbate R; Antoniucci D
JAMA; 2011 Sep; 306(11):1215-23. PubMed ID: 21934054
[TBL] [Abstract][Full Text] [Related]
18. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
[TBL] [Abstract][Full Text] [Related]
19. Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
Cuisset T; Quilici J; Grosdidier C; Fourcade L; Gaborit B; Pankert M; Molines L; Morange PE; Bonnet JL; Alessi MC
Am J Cardiol; 2011 Nov; 108(10):1411-6. PubMed ID: 21872198
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.
Gurbel PA; Bliden KP; Saucedo JF; Suarez TA; DiChiara J; Antonino MJ; Mahla E; Singla A; Herzog WR; Bassi AK; Hennebry TA; Gesheff TB; Tantry US
J Am Coll Cardiol; 2009 Feb; 53(8):648-57. PubMed ID: 19232896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
